Research and Practice in Intellectual and Developmental Disabilities is an esteemed journal published by Routledge Journals, Taylor & Francis Ltd, dedicated to advancing knowledge and practices in the fields of intellectual and developmental disabilities. Since its inception in 2014, this journal has played a pivotal role in disseminating high-quality research and innovative practices through a rigorous peer-review process, aimed at enhancing the lives of individuals with disabilities. With an ISSN of 2329-7018 and an E-ISSN of 2329-7026, this journal focuses on a spectrum of interdisciplinary approaches, including the latest in developmental neuroscience and clinical neurology. Despite its Q4 and Q3 rankings in related categories such as Developmental Neuroscience and Neurology, respectively, it continues to attract contributions from a diverse array of scholars, providing vital insights and evidence-based practices. While remaining firmly committed to academic integrity and quality, the journal serves as a critical platform for researchers, professionals, and students alike, who are keen to address contemporary challenges and foster effective interventions within the realm of intellectual and developmental disabilities.

Journal of Policy and Practice in Intellectual Disabilities, published by WILEY, stands as a prominent platform dedicated to advancing our understanding and application of policies and practices that affect individuals with intellectual disabilities. Established in 2009, this esteemed journal addresses critical issues in the field of social sciences, primarily focusing on health and public health, evident from its high rankings in Q1 and Q2 categories in the 2023 metrics. With an ISSN of 1741-1122 and an E-ISSN of 1741-1130, it operates out of the United Kingdom, offering vital insights that inform service delivery, policy-making, and research initiatives surrounding intellectual disabilities. Though not an open access journal, it provides a rich resource for researchers, professionals, and students aiming to contribute to meaningful change in this vital area of social welfare. The journal’s commitment to rigorous scholarship is reflected in its Scopus rankings, highlighting its influence as a pivotal resource for those seeking to enhance and innovate practices that uplift community well-being.

Schizophrenia Research is a premier academic journal focused on innovative research within the domain of psychiatry and mental health, published by Elsevier. With its ISSN 0920-9964 and E-ISSN 1573-2509, the journal has established a strong presence since its inception in 1988, evolving to publish cutting-edge findings up to 2024. Positioned in Q1 in Psychiatry and Mental Health and Q2 in Biological Psychiatry, it ranks impressively in the 83rd percentile among its peers, according to Scopus, ranking #93/567 in the field of Medicine, and #12/51 in Neuroscience. This journal serves as a vital platform for the dissemination of significant scientific advancements and theoretical insights into schizophrenia, fostering a deeper understanding of mental illnesses. Although it operates on a subscription basis, its critical role in informing both ongoing research and clinical practices cannot be overstated, making it an essential resource for researchers, clinicians, and students alike. Join a global community dedicated to improving mental health outcomes and advancing the study of schizophrenia through this reputable publication.

Annals of General Psychiatry is a leading open-access journal published by BMC, dedicated to advancing the field of psychiatry and mental health. Since its inception in 2005, the journal has provided a robust platform for researchers to disseminate peer-reviewed clinical and experimental studies, case reports, and reviews that address the broad spectrum of psychiatric disorders. With an impressive Q1 ranking in Psychiatry and Mental Health for 2023, and a notable Scopus rank of #128 out of 567 in its category, the journal plays a pivotal role in disseminating high-quality, impactful research within the global scientific community. The open access model guarantees wide visibility and accessibility of research findings, ensuring that professionals, students, and policymakers can utilize the latest advancements in the psychiatric field. The journal's presence from 2002 to 2024 further demonstrates its commitment to contributing valuable insights that are relevant to contemporary challenges in mental health.

Sante Mentale au Quebec is a prominent journal dedicated to the exploration and dissemination of research in the fields of Clinical Psychology, Psychiatry, and Mental Health. Published by the Revue Sante Mentale Quebec, this journal has been serving the academic community since its inception, with converged publication years from 1990 to 1998 and from 2004 to 2024. Despite its current Q4 rankings in both Clinical Psychology and Psychiatry and Mental Health categories, Sante Mentale au Quebec remains a crucial platform for sharing innovative research and advancements in mental health care and psychology practices within Canada and beyond. Researchers, professionals, and students can engage with a variety of articles that encompass empirical studies, literature reviews, and theoretical discussions, contributing to the betterment of mental health outcomes. This journal plays an essential role in fostering dialogue and collaboration among mental health professionals, ultimately aiming to enhance the quality of mental health services.

The Journal of Applied Research in Intellectual Disabilities, published by Wiley, is a pioneering platform dedicated to advancing knowledge and promoting best practices in the field of intellectual disabilities. With an impressive impact factor reflecting its significance—ranking in the Q2 category for Developmental and Educational Psychology and the Q1 category for Education in 2023—this journal serves as an essential resource for researchers, practitioners, and students alike. Its wide contribution to social sciences is evidenced by its high standings in Scopus rankings, positioned at Rank #297 in Education and Rank #103 in Developmental and Educational Psychology. This journal not only fosters innovative empirical and theoretical research but also encourages the dissemination of practical solutions to enhance the quality of life for individuals with intellectual disabilities. With access options available to meet diverse needs, including open access, it strives to make impactful research widely available, bridging the gap between academic research and practical application.

PSYCHIATRISCHE PRAXIS, an esteemed journal published by GEORG THIEME VERLAG KG, serves as a vital resource in the field of psychiatry and mental health. Established in 1974, this German journal offers a compelling mix of original research, clinical insights, and theoretical discussions, contributing to the advancement of knowledge up to its historical convergence slated for 2024. With a distinguished Scopus ranking of #250 out of 567 in the Psychiatry and Mental Health category, and a 2023 Category Quartile of Q3, it stands as a significant platform for researchers and professionals. The journal does not currently offer Open Access options; however, its reputation and impact within the community place it as a valuable asset for those dedicated to understanding and improving mental health practices. PSYCHIATRISCHE PRAXIS engages its readership with innovative studies and authoritative viewpoints, making it an essential tool for scholars, practitioners, and students aiming to enrich their insight into psychiatric care and research.

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.

BMJ Mental Health, published by the esteemed BMJ PUBLISHING GROUP, is a pioneering open-access journal dedicated to advancing research and knowledge in the field of Psychiatry and Mental Health. Launched in 2023, this journal has rapidly established itself within the academic community, achieving a prestigious Q1 ranking and a ranking of #123 out of 567 in its category, placing it in the 78th percentile according to Scopus. With its base in the United Kingdom, the journal aims to foster impactful research through its commitment to accessibility, allowing professionals, researchers, and students alike to engage with high-quality content freely. The E-ISSN: 2755-9734 enables seamless digital access to cutting-edge studies, reviews, and perspectives that address the complexities of mental health, thereby paving the way for better practices and innovations in mental health care. Join a community of dedicated scholars and practitioners in reshaping the landscape of mental health research with BMJ Mental Health.

BMC Psychiatry is a leading open-access journal published by BMC, dedicated to advancing the field of psychiatry and mental health. With its E-ISSN 1471-244X, the journal has been at the forefront of disseminating high-quality research since its inception in 2001, and it proudly maintains a Q1 ranking among psychiatry and mental health journals, reflecting its significant impact and relevance within the research community. Based in the United Kingdom, BMC Psychiatry boasts a commendable Scopus ranking of #158 out of 567 in the psychiatry and mental health category, placing it in the 72nd percentile. The journal serves as a vital platform for scholars, clinicians, and students alike, providing them with access to groundbreaking studies, innovative methodologies, and emerging trends in mental health. By fostering a collaborative environment, BMC Psychiatry not only enriches the academic landscape but also contributes to evidence-based practice and policy in mental health care.